Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comDescription:
The investigators will determine the proportion of CUP patients in whom the primary tumor can be identified by [18F]F-FAPI PET-CT.
Sponsor:
Erasmus Medical Center
Phase:
N/A
Contacts:
Sophie Veldhuijzen van Zanten, MD, PhDfapiforcup@erasmusmc.nl
0107042006
Government Study Link:
NCT06644716 - Click here to see study onClinicalTrials.gov
Help us improve your experience